Poland· PL-100379730
Camlocor
A candesartan und amlodipin product containing candesartanum cilexetili + amlodipinum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Candesartan und amlodipin is registered in 6 of 19 countries.
Countries holding a registration under ATC C09DB07 (candesartan und amlodipin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Candesartan und amlodipin · ATC C09DB07
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Italyprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Candesartanum cilexetili + Amlodipinum
- Manufacturer
- Krka, d.d., Novo mesto
- Country
- Poland (PL)
- ATC code
- C09DB07
- ATC class
- Candesartan und Amlodipin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 22
1 priced- gtin05909991367497
- gtin05909991367503
- gtin05909991367633
- gtin05909991367640
- gtin05909991367657
- gtin0590999136751028 szt.PLN 12.87
- gtin05909991367459
- gtin05909991367466
- gtin05909991367473
- gtin05909991367480
- gtin05909991367527
- gtin05909991367534
- gtin05909991367541
- gtin05909991367558
- gtin05909991367565
- gtin05909991367572
- gtin05909991367589
- gtin05909991367596
- gtin05909991367602
- gtin05909991367619
- gtin05909991367626
- gtin05909991367664
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
8 interactions on record for candesartan und amlodipin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Candesartan und amlodipin · interactions on record
8 records
8 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09DB07
Candesartan und amlodipin, as other registers publish it.
- FinlandAltensilLusomedicamenta Sociedade Técnica Farmacêutica SA
- FinlandAltensilLusomedicamenta Sociedade Técnica Farmacêutica SA
- FinlandAltensilLusomedicamenta Sociedade Técnica Farmacêutica SA
- FinlandAltensilLusomedicamenta Sociedade Técnica Farmacêutica SA
- CzechiaBILAMCARSwyssi AG, Frankfurt am Main
- CzechiaBILAMCARSwyssi AG, Frankfurt am Main
- CzechiaBILAMCARSwyssi AG, Frankfurt am Main
- CzechiaBILAMCARSwyssi AG, Frankfurt am Main
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8b77e0c-6927-456c-be16-92e31dad6bce GET /v1/drugs/e8b77e0c-6927-456c-be16-92e31dad6bce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "8 mg + 5 mg",
"packaging": "05909991367459 ¦ Rp ¦ Skasowane ¦ 127405\n7 tabl. w blistrze perforowanym\n05909991367466 ¦ Rp ¦ Skasowane ¦ 127406\n7 tabl. w blistrze\n05909991367473 ¦ Rp ¦ Skasowane ¦ 127407\n10 tabl. w blistrze\n05909991367480 ¦ Rp ¦ Skasowane ¦ 127408\n10 tabl. w blistrze perforowanym\n05909991367497 ¦ Rp ¦ Skasowane ¦ 127409\n14 tabl. w blistrze perforowanym\n05909991367503 ¦ Rp ¦ Skasowane ¦ 127410\n14 tabl. w blistrze\n05909991367510 ¦ Rp ¦ 127411\n28 tabl. w blistrze\n05909991367527 ¦ Rp ¦ 127412\n28 tabl. w blistrze perforowanym\n05909991367534 ¦ Rp ¦ 127413\n30 tabl. w blistrze\n05909991367541 ¦ Rp ¦ 127414\n30 tabl. w blistrze perforowanym\n05909991367558 ¦ Rp ¦ 127415\n50 tabl. w blistrze\n05909991367565 ¦ Rp ¦ 127416\n50 tabl. w blistrze perforowanym\n05909991367572 ¦ Rp ¦ 127417\n56 tabl. w blistrze\n05909991367589 ¦ Rp ¦ 127418\n56 tabl. w blistrze perforowanym\n05909991367596 ¦ Rp ¦ 127419\n60 tabl. w blistrze\n05909991367602 ¦ Rp ¦ 127420\n60 tabl. w blistrze perforowanym\n05909991367619 ¦ Rp ¦ 127421\n90 tabl. w blistrze\n05909991367626 ¦ Rp ¦ 127422\n90 tabl. w blistrze perforowanym\n05909991367633 ¦ Rp ¦ 127423\n98 tabl. w blistrze\n05909991367640 ¦ Rp ¦ 127424\n98 tabl. w blistrze perforowanym\n05909991367657 ¦ Rp ¦ 127425\n100 tabl. w blistrze\n05909991367664 ¦ Rp ¦ 127426\n100 tabl. w blistrze perforowanym",
"substance": "Candesartanum cilexetili 8 mg + Amlodipinum 5 mg",
"common_name": "Candesartanum cilexetili + Amlodipinum",
"pl_product_id": "100379730",
"pozwolenie_nr": "24633",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about candesartan und amlodipin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.